Subcutaneous Tumor
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Phase I Study of Tolododekin Alfa (ANK-101) in Advanced Solid Tumors (NCT06171750) | Ankyra Therapeutics, Inc | 2024-01-19 |
Track Subcutaneous Tumor automatically
Every clearance here is in the API, with alerts when new ones post.